| __timestamp | Amneal Pharmaceuticals, Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 17763000 |
| Thursday, January 1, 2015 | 109679000 | 22180000 |
| Friday, January 1, 2016 | 118757000 | 37257000 |
| Sunday, January 1, 2017 | 109046000 | 27367000 |
| Monday, January 1, 2018 | 230435000 | 64770000 |
| Tuesday, January 1, 2019 | 289598000 | 74986000 |
| Wednesday, January 1, 2020 | 326727000 | 79256000 |
| Friday, January 1, 2021 | 365504000 | 100156000 |
| Saturday, January 1, 2022 | 399700000 | 131408000 |
| Sunday, January 1, 2023 | 429675000 | 152946000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, understanding the financial strategies of key players is crucial. Amneal Pharmaceuticals, Inc. and Dynavax Technologies Corporation have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses from 2014 to 2023. Amneal's SG&A expenses have surged by over 400% during this period, reflecting a strategic investment in growth and market expansion. In contrast, Dynavax has seen a more modest increase of approximately 760%, indicating a more conservative approach.
The year 2018 marked a significant turning point for both companies, with Amneal's expenses nearly doubling, while Dynavax's expenses increased by 74%. This divergence highlights differing business strategies and market responses. As we look to the future, these trends offer valuable insights into how each company navigates the challenges and opportunities within the pharmaceutical industry.
Breaking Down SG&A Expenses: Pfizer Inc. vs Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Insmed Incorporated vs Dynavax Technologies Corporation
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Catalent, Inc. or Dynavax Technologies Corporation
Selling, General, and Administrative Costs: Ascendis Pharma A/S vs Dynavax Technologies Corporation
Breaking Down SG&A Expenses: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.
Selling, General, and Administrative Costs: Rhythm Pharmaceuticals, Inc. vs Dynavax Technologies Corporation
MannKind Corporation and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Dynavax Technologies Corporation and Galapagos NV
SG&A Efficiency Analysis: Comparing Dynavax Technologies Corporation and Novavax, Inc.